To test or not to test.: Usefulness of Helicobacter pylori determination after eradication therapy in duodenal ulcer patients.: A cost-effectiveness analysis in the primary care setting

被引：0
|
作者：
Gené, E
Calvet, X
Azagra, R
机构：
[1] Corp Sanit Del Parc Tauli, Med Serv, Sabadell, Spain
[2] ABS Badia del Valles, Dap Cerdanyola, Barcelona, Spain
来源：
GUT | 1999年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A128 / A128
页数：1
相关论文
共 50 条
  • [21] Cost/effectiveness analysis of two strategies for Helicobacter pylori eradication:: results of a prospective and randomized study in primary care setting
    Gomollón, F
    Valdepérez, J
    Garuz, R
    Fuentes, J
    Barrera, F
    Malo, J
    Tirado, M
    Simón, MA
    [J]. MEDICINA CLINICA, 2000, 115 (01): : 1 - 6
  • [22] Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy
    Seko, Takayuki
    Tachi, Tomoya
    Hatakeyama, Hiroo
    Noguchi, Yoshihiro
    Teramachi, Hitomi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (06)
  • [23] Short triple therapy for Helicobacter pylori (HP) eradication in duodenal ulcer (DU) patients. Could it be even shorter?
    Chahin, NJ
    Rigo, GP
    Perini, M
    Manenti, F
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A78 - A78
  • [24] Cost-effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer
    Zheng, Hanrui
    Xie, Qian
    Zhan, Mei
    Jin, Chaohui
    Li, Qiu
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 77 - 85
  • [25] Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model
    Han, Yan
    Yan, Tianlian
    Ma, Han
    Yao, Xin
    Lu, Chao
    Li, Youming
    Li, Lan
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (06) : 1679 - 1688
  • [26] Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model
    Yan Han
    Tianlian Yan
    Han Ma
    Xin Yao
    Chao Lu
    Youming Li
    Lan Li
    [J]. Digestive Diseases and Sciences, 2020, 65 : 1679 - 1688
  • [27] Which test is best for Helicobacter pylori?: A cost-effectiveness model using decision analysis
    Elwyn, Glyn
    Taubert, Mark
    Davies, Shan
    Brown, Ginevra
    Allison, Miles
    Phillips, Ceri
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2007, 57 (538): : 401 - 403
  • [28] Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis
    Kowada, Akiko
    Asaka, Masahiro
    [J]. HELICOBACTER, 2022, 27 (03)
  • [29] Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal UlcerAn Analysis of Triple Therapy Versus Two Dual Therapy Alternatives
    Gunnel Ragnarson Tennvall
    Anna Norinder
    Bo Ohlin
    [J]. PharmacoEconomics, 1999, 16 : 297 - 306
  • [30] ERADICATION OF HELICOBACTER PYLORI WITH VONOPRAZAN-BISMUTH CONTAINING QUADRUPLE THERAPY IN CHINA: A COST-EFFECTIVENESS ANALYSIS
    Zhu, S.
    Li, Y.
    Liu, Y.
    Sheng, Y.
    Li, H.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S146 - S146
12345